Actively Recruiting
Clinical Evaluation of Pre-hospital Stroke Triage Devices - Electroencephalography
Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2025-10-03
275
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating a portable EEG-based triage device called StrokePointer to detect large vessel occlusion (LVO) strokes in patients suspected of acute stroke in the pre-hospital setting. The study aims to validate the safety and effectiveness of StrokePointer, which could help ambulance personnel identify LVO strokes early and reduce delays in transferring patients to specialized hospitals capable of performing endovascular thrombectomy (EVT). Each participant will undergo a single dry electrode EEG measurement using the StrokePointer headset, which records brain activity for about two minutes. The device includes a headset, portable suitcase with a mobile computing device and EEG amplifier, and software for data acquisition and analysis. The study is a prospective, multi-center cohort design focused on adult patients with suspected stroke symptoms starting less than 24 hours prior. Participants will have EEG data collected and analyzed to assess data quality and diagnostic accuracy for LVO stroke detection. Clinical and radiological information will also be gathered. Researchers will monitor safety by tracking adverse device-related events and skin reactions. The study will evaluate usability based on ambulance personnel feedback. The total involvement includes the EEG procedure performed in the ambulance before hospital arrival, with outcomes measured within 24 hours of symptom onset.
CONDITIONS
Brief Title
Clinical Evaluation of EEG Device for the Triage of Stroke Patients in the Ambulance
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Suspected acute stroke as judged by ambulance personnel
- Age 18 years or older
- Onset of symptoms or last seen well less than 24 hours ago
- Written informed consent by patient or legal representative (deferred)
You will not qualify if you...
- Injuries or infections of the scalp where the EEG headset would be placed
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - Up to 24 hours
Participants are screened for eligibility to participate in the trial.
1 visit (in-person during ambulance transport)
Duration - Approximately 2 minutes
Participants undergo a single dry electrode EEG measurement with the StrokePointer device to collect EEG data for stroke triage.
1 visit (in-person during ambulance transport)
Trial Site Locations
Total: 1 location
1
Amsterdam University Medical Centers, location AMC
Amsterdam, North Holland, Netherlands, 1105AZ
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here